Together Pharma

Together Pharma Financing Cash Flow

The Net Financing Cash Flow of Together Pharma (TGTR.TA) as of Nov 3, 2026 is 3.37 M ILS. In the previous year, Net Financing Cash Flow was -14.92 M ILS — a change of -122.61% (higher).

Financing Cash Flow

3.37 MILS

YoY

-122.61%

Last updated:

Net Financing Cash Flow of Together Pharma is 2024 3.37 M ILS. Net Financing Cash Flow of Together Pharma was 2023 -14.92 M ILS. It decreases by -122.61% higher compared to the previous year.

The Together Pharma Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2017
3.59 M ILS
Jan 1, 2018
18.92 M ILS
Jan 1, 2019
28.04 M ILS
Jan 1, 2020
40.23 M ILS
Jan 1, 2021
48.84 M ILS
Jan 1, 2022
-19.14 M ILS
Jan 1, 2023
-14.92 M ILS
Jan 1, 2024
3.37 M ILS
The Together Pharma Financing Cash Flow history
YEARFinancing Cash FlowYoY
3.37 MILS-122.61%
-14.92 MILS-22.06%
-19.14 MILS-139.20%
48.84 MILS+21.42%
40.23 MILS+43.46%
28.04 MILS+48.23%
18.92 MILS+426.42%
3.59 MILS+287.46%
927,400.00ILS-86.31%
6.77 MILS+34.21%
5.05 MILS—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Together Pharma Stock analysis

What does Together Pharma do? Together Pharma Ltd. operates through the multiplication, cultivation, production, storage, marketing, and distribution of medical products based on the cannabis plant. The company markets three specific digital products: ExactMe, which serves as a search engine for recruiters to find jobseekers; POP CV, a curriculum vitae center system that assesses, ranks, and matches resumes sent to employers; and SkilliQ, which functions as a job board. Together Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Together Pharma stock

Net Financing Cash Flow of Together Pharma is 3.37 M ILS in 2024.

Net Financing Cash Flow of Together Pharma changed from -14.92 M ILS to 3.37 M ILS, representing a -122.61% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow Together Pharma since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's ILS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Together Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Together Pharma

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Together Pharma